Market Closed -
Xetra
11:35:04 2024-05-20 am EDT
|
After market
11:55:43 am
|
28.66
EUR
|
+0.30%
|
|
28.7
|
+0.12%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
71,530
|
47,309
|
46,174
|
47,476
|
33,039
|
28,078
|
-
|
-
|
Enterprise Value (EV)
1 |
105,598
|
84,884
|
79,140
|
78,749
|
33,039
|
60,478
|
58,244
|
54,709
|
P/E ratio
|
17.5
x
|
-4.51
x
|
46.1
x
|
11.5
x
|
-11.2
x
|
12.4
x
|
8.75
x
|
8.36
x
|
Yield
|
3.85%
|
4.15%
|
4.26%
|
4.97%
|
-
|
0.38%
|
0.78%
|
3.82%
|
Capitalization / Revenue
|
1.64
x
|
1.14
x
|
1.05
x
|
0.94
x
|
0.69
x
|
0.6
x
|
0.59
x
|
0.58
x
|
EV / Revenue
|
2.43
x
|
2.05
x
|
1.8
x
|
1.55
x
|
0.69
x
|
1.28
x
|
1.22
x
|
1.13
x
|
EV / EBITDA
|
9.18
x
|
7.41
x
|
7.08
x
|
5.83
x
|
3.11
x
|
5.71
x
|
5.37
x
|
4.98
x
|
EV / FCF
|
19
x
|
34.2
x
|
31.9
x
|
19
x
|
-
|
17.9
x
|
11.9
x
|
12.4
x
|
FCF Yield
|
5.26%
|
2.93%
|
3.13%
|
5.26%
|
-
|
5.58%
|
8.38%
|
8.03%
|
Price to Book
|
1.51
x
|
1.55
x
|
1.4
x
|
1.22
x
|
-
|
0.83
x
|
0.75
x
|
0.68
x
|
Nbr of stocks (in thousands)
|
982,424
|
982,424
|
982,424
|
982,424
|
982,424
|
982,424
|
-
|
-
|
Reference price
2 |
72.81
|
48.16
|
47.00
|
48.32
|
33.63
|
28.58
|
28.58
|
28.58
|
Announcement Date
|
2/27/20
|
2/25/21
|
3/1/22
|
2/28/23
|
3/5/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
43,545
|
41,400
|
44,081
|
50,739
|
47,637
|
47,124
|
47,885
|
48,614
|
EBITDA
1 |
11,503
|
11,461
|
11,179
|
13,513
|
10,632
|
10,600
|
10,838
|
10,993
|
EBIT
1 |
7,007
|
7,095
|
7,295
|
9,257
|
7,589
|
6,666
|
7,046
|
7,205
|
Operating Margin
|
16.09%
|
17.14%
|
16.55%
|
18.24%
|
15.93%
|
14.15%
|
14.72%
|
14.82%
|
Earnings before Tax (EBT)
1 |
2,880
|
-17,250
|
2,046
|
4,670
|
-1,621
|
4,021
|
4,089
|
4,498
|
Net income
1 |
4,091
|
-10,495
|
1,000
|
4,150
|
-2,941
|
2,480
|
3,222
|
3,475
|
Net margin
|
9.39%
|
-25.35%
|
2.27%
|
8.18%
|
-6.17%
|
5.26%
|
6.73%
|
7.15%
|
EPS
2 |
4.170
|
-10.68
|
1.020
|
4.220
|
-2.990
|
2.296
|
3.266
|
3.418
|
Free Cash Flow
1 |
5,557
|
2,485
|
2,478
|
4,144
|
-
|
3,376
|
4,884
|
4,395
|
FCF margin
|
12.76%
|
6%
|
5.62%
|
8.17%
|
-
|
7.16%
|
10.2%
|
9.04%
|
FCF Conversion (EBITDA)
|
48.31%
|
21.68%
|
22.17%
|
30.67%
|
-
|
31.85%
|
45.06%
|
39.98%
|
FCF Conversion (Net income)
|
135.83%
|
-
|
247.8%
|
99.86%
|
-
|
136.15%
|
151.57%
|
126.48%
|
Dividend per Share
2 |
2.800
|
2.000
|
2.000
|
2.400
|
-
|
0.1100
|
0.2243
|
1.093
|
Announcement Date
|
2/27/20
|
2/25/21
|
3/1/22
|
2/28/23
|
3/5/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2020 S2
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
22,899
|
18,501
|
11,118
|
14,639
|
12,819
|
11,281
|
12,000
|
14,389
|
11,044
|
10,342
|
11,862
|
13,765
|
11,024
|
24,831
|
10,375
|
11,991
|
22,454
|
-
|
-
|
EBITDA
1 |
7,274
|
-
|
2,395
|
5,251
|
3,349
|
2,451
|
2,462
|
4,471
|
2,527
|
1,685
|
3,023
|
4,412
|
2,341
|
6,738
|
1,623
|
2,315
|
3,941
|
-
|
-
|
EBIT
1 |
-
|
-
|
1,383
|
4,172
|
2,280
|
1,352
|
1,453
|
3,404
|
1,534
|
709
|
1,942
|
3,299
|
1,263
|
-
|
785.1
|
1,274
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
12.44%
|
28.5%
|
17.79%
|
11.98%
|
12.11%
|
23.66%
|
13.89%
|
6.86%
|
16.37%
|
23.97%
|
11.46%
|
-
|
7.57%
|
10.63%
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
1,497
|
3,722
|
-523
|
601
|
870
|
2,606
|
-1,574
|
-4,297
|
1,644
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-
|
-
|
1,161
|
3,291
|
-298
|
546
|
611
|
2,178
|
-1,887
|
-4,569
|
1,337
|
2,000
|
83.94
|
-
|
-305.5
|
-201.6
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
10.44%
|
22.48%
|
-2.32%
|
4.84%
|
5.09%
|
15.14%
|
-17.09%
|
-44.18%
|
11.27%
|
14.53%
|
0.76%
|
-
|
-2.94%
|
-1.68%
|
-
|
-
|
-
|
EPS
2 |
-
|
-
|
1.180
|
3.350
|
-0.3000
|
0.5600
|
0.6200
|
2.220
|
-1.920
|
-4.660
|
1.360
|
2.040
|
0.0854
|
-
|
-0.3110
|
-0.2052
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
2.000
|
-
|
-
|
-
|
2.400
|
-
|
-
|
-
|
-
|
-
|
0.0275
|
-
|
0.0275
|
0.0275
|
-
|
0.0275
|
0.0275
|
Announcement Date
|
8/4/20
|
2/25/21
|
3/1/22
|
5/10/22
|
8/4/22
|
11/8/22
|
2/28/23
|
5/11/23
|
8/8/23
|
11/8/23
|
3/5/24
|
5/14/24
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
34,068
|
37,575
|
32,966
|
31,273
|
-
|
32,400
|
30,166
|
26,632
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.962
x
|
3.279
x
|
2.949
x
|
2.314
x
|
-
|
3.057
x
|
2.783
x
|
2.423
x
|
Free Cash Flow
1 |
5,557
|
2,485
|
2,478
|
4,144
|
-
|
3,376
|
4,884
|
4,395
|
ROE (net income / shareholders' equity)
|
13.5%
|
16.2%
|
20.1%
|
8.65%
|
-
|
14.5%
|
15%
|
13.5%
|
ROA (Net income/ Total Assets)
|
3.23%
|
-8.63%
|
0.84%
|
3.39%
|
-
|
-0.1%
|
1.58%
|
2.65%
|
Assets
1 |
126,495
|
121,611
|
118,526
|
122,560
|
-
|
-2,479,735
|
204,005
|
131,054
|
Book Value Per Share
2 |
48.20
|
31.10
|
33.60
|
39.50
|
-
|
34.50
|
38.30
|
42.30
|
Cash Flow per Share
2 |
8.360
|
4.990
|
5.180
|
7.220
|
-
|
5.130
|
8.360
|
8.330
|
Capex
1 |
2,650
|
2,418
|
2,611
|
2,949
|
-
|
2,996
|
2,912
|
2,987
|
Capex / Sales
|
6.09%
|
5.84%
|
5.92%
|
5.81%
|
-
|
6.36%
|
6.08%
|
6.15%
|
Announcement Date
|
2/27/20
|
2/25/21
|
3/1/22
|
2/28/23
|
3/5/24
|
-
|
-
|
-
|
Last Close Price
28.58
EUR Average target price
36.9
EUR Spread / Average Target +29.13% Consensus |
1st Jan change
|
Capi.
|
---|
| -15.02% | 30.53B | | +32.09% | 693B | | +29.39% | 584B | | -1.34% | 372B | | +20.34% | 332B | | +7.39% | 294B | | +14.25% | 239B | | -3.03% | 211B | | +10.02% | 210B | | +8.49% | 168B |
Other Pharmaceuticals
|